Phase 2 Readout
ALZN: Phase 2 Readout: al001
December 31, 2026 · al001. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- December 31, 2026
- Company
- Alzamend Neuro, Inc. (ALZN)
- Drug
- al001
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Phase 2 Readout~quarter
Phase 2 Readout: al001
- Company
- Alzamend Neuro, Inc. (ALZN)
- Drug
- al001
- Indication
- bipolar disorder type 1